OPKO Health (OPK) Fundamental Analysis: Revenue, Earnings & Valuation

2.00 / 10

Underperform

Fundamental metrics rate the stock as Underperform, scoring 2/10. Inventory turnover (6.54) is decent, and interest coverage (35.1) is strong, yet revenue YoY falls –14.9% and long‑term debt to working capital (1.19) raise concerns. Overall, fundamentals are lackluster.

Analysis Checks(4/10)

Revenue-MV

Value0.18

Score2/3

Weight40.26%

1M Return4.88%

Total operating revenue (YoY growth rate %)

Value-14.90

Score1/3

Weight-2.49%

1M Return-0.38%

Inventory turnover ratio

Value6.54

Score2/3

Weight-7.24%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value22.09

Score3/3

Weight11.79%

1M Return1.67%

PB-ROE

Value-0.63

Score1/3

Weight51.30%

1M Return7.56%

Long-term debt to working capital ratio (%)

Value1.19

Score1/3

Weight-4.27%

1M Return-0.65%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-7.36%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value-14.90

Score1/3

Weight-1.95%

1M Return-0.30%

Cost of sales ratio (%)

Value66.07

Score1/3

Weight-37.41%

1M Return-7.95%

Asset-MV

Value-0.55

Score1/3

Weight57.36%

1M Return6.31%

Is OPK undervalued or overvalued?

OPK scores 2.00/10 on fundamentals and holds a Premium valuation at present. Backed by its -17.14% ROE, -37.19% net margin, -3.83 P/E ratio, 0.68 P/B ratio, and -275.00% earnings growth, these metrics solidify its Underperform investment rating.